Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Soleno Therapeutics Inc. (SLNO)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 9
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Soleno Therapeutics, Inc. - SLNO

Market reaction Comment Full text

Ventyx Biosciences (VTYX)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 8
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ventyx Biosciences, Inc. - VTYX

Market reaction Comment Full text

Mereo BioPharma (MREO)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 11
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Mereo BioPharma Group plc - MREO

Market reaction Comment Full text

Ultragenyx Pharmaceutical Inc (RARE)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 6
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. - RARE

Market reaction Comment Full text

Anavex Life Sciences Corp. (AVXL)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 11
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anavex Life Sciences Corp. - AVXL

Market reaction Comment Full text

Quest Diagnostics Incorporated (DGX)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 5
  • 1 comments

Quest Diagnostics to Release Fourth Quarter and Full Year 2025 Financial Results on February 10, 2026

Market reaction Comment Full text

RxSight Inc. (RXST)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 11
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST

Market reaction Comment Full text

Corcept Therapeutics Incorporated (CORT)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 12
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Corcept Therapeutics Incorporated - CORT

Market reaction Comment Full text

Galectin Therapeutics Inc. (GALT)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 7
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Galectin Therapeutics Inc. - GALT

Market reaction Comment Full text

XOMA Corporation (XOMA)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 7
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of XOMA Royalty Corporation - XOMA

Market reaction Comment Full text

Nektar Therapeutics (NKTR)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 10
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nektar Therapeutics - NKTR

Market reaction Comment Full text

Insmed Inc (INSM)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 6
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Insmed Incorporated - INSM

Market reaction Comment Full text

Rezolute Inc. (RZLT)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 9
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rezolute, Inc. - RZLT

Market reaction Comment Full text

Organogenesis Holdings Inc. (ORGO)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 9
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organogenesis Holdings Inc. - ORGO

Market reaction Comment Full text

Outset Medical Inc. (OM)

  • Business News
  • Jan. 08, 2026, 15:00 UTC
  • 6
  • 1 comments

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Outset Medical, Inc. - OM

Market reaction Comment Full text
  • Previous
  • 385
  • 386
  • 387
  • 388
  • 389
  • Next

Search

News categories

  • Technical Exchange News(10908)
  • Event(2323)
  • SEC News(190525)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124901)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin